Lefamulin
INDICATIONS
FDA
FDA
- Treatment of adults with community-acquired bacterial pneumonia (CABP) caused by susceptible microorganisms.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- No established non-FDA-approved clinical indications.
- In vitro activity has been demonstrated against MRSA and some isolates of vancomycin-resistant E. faecium and multidrug-resistant N. gonorrhoeae.
- Limited clinical experience with multidrug-resistant M. genitalium has shown inconsistent efficacy.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: November 7, 2026
Citation
Soto, Caitlin, and Fidelia Bernice. "Lefamulin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2026. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540731/all/Lefamulin.
Soto C, Bernice F. Lefamulin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540731/all/Lefamulin. Accessed November 17, 2026.
Soto, C., & Bernice, F. (2026). Lefamulin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540731/all/Lefamulin
Soto C, Bernice F. Lefamulin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. [cited 2026 November 17]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540731/all/Lefamulin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lefamulin
ID - 540731
A1 - Soto,Caitlin,PharmD, BCIDP
AU - Bernice,Fidelia,Pharm.D.
Y1 - 2026/11/07/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540731/all/Lefamulin
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -

Johns Hopkins ABX Guide

